B. Hackanson

Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancer

M. Gerken, H. Schlitt, H. Messmann, 2022, ESMO open.

BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.

K. Geiger, M. Follo, A. Mehlhorn, 2007, Cytotherapy.

Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia.

M. Grever, J. Byrd, C. Plass, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma

M. Merz, S. Knop, T. Dechow, 2020, Annals of Hematology.

[Epigenetic changes in malignant cells].

M. Lübbert, B. Hackanson, 2011, Deutsche Medizinische Wochenschrift.

Phase Ib study of BI 836880 (VEGF/Ang2 nanobody) plus ezabenlimab (BI 754091; anti-PD-1 antibody) in patients (pts) with solid tumors.

N. Girard, E. Felip, Dong-Wan Kim, 2021 .